Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteacceleronpharma.com
CategoryBioTech
Phone617-649-9200
Emailinfo@acceleronpha...
Employees
Founded2004
DescriptionGrowth and Differentiation Factor

Offices

Cambridge, USA
128 Sidney Street
Cambridge, MA, 02139
USA

People

CEO, Founder
SVP, Manufacturing
VP and General Counsel
VP, Human Resources
VP, Medical Research
VP, Regulatory Affairs
VP, Quality
VP, Finance
Show All People

Funding

TOTAL $114M
FUNDING TOTAL $114M
Series B, 8/2006
OrbiMed Advisors
Advanced Technology Ventures
Flagship Ventures
Polaris Partners
Sutter Hill Ventures
Venrock
$30M
Series C, 10/2007
$31M
Venture Round, 12/2009
$11M
Venture Round, 6/2010
Venrock
OrbiMed Advisors
Advanced Technology Ventures
Flagship Ventures
Polaris Partners
$10.3M
Grant, 1/2011
$1.5M
Series F, 12/2011
Celgene
$30M

Tags

Acceleron Pharma

Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases. Its products include ACE-011 Program, a novel bone forming agent that helps to treat cancer-related bone loss; ACE-031 Program that helps to treat diseases involving the loss of muscle mass, strength, and function in diseases, including muscular dystrophy, amyotrophic lateral sclerosis, and cancer-related muscle loss; and ACE-041, a protein therapeutic that binds a member of the growth and differentiation factor family necessary for angiogenesis. It develops therapies based on growth and differentiation factors that regulate the cellular proliferation, differentiation, and survival of a range of tissue types. The company offers treatments for cancer-related bone loss, cancer-related muscle loss, neuromuscular diseases, and metabolic disorders. Acceleron Pharma, Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.

Recent Milestones

Videos

Screenshots

Acceleron Pharma screenshot
Above: Home Page
Uploaded: 12/16/09

Sources

  1. Acceleron Pharma Closes $30M Series B Financing (acceleronpharma.com) [edit]
  2. Acceleron to grow staff, manufacturing in Cambridge (masshightech.com) [edit]
  3. Acceleron Pharma grows further with almost $11M financing (masshightech.com) [edit]
  4. SEC (sec.gov) [edit]
  5. Acceleron DMD drug target draws $1.5M grant (masshightech.com) [edit]
  6. Acceleron Pharma Raises $30M in Funding (finsmes.com) [edit]
  7. Acceleron signs lucrative development deal with Shire (masshightech.com) [edit]
    Acceleron Pharma, Shire Form $498M Drug Development Alliance (fis.dowjones.com) [edit]
    Qteros vet McLaughlin named Acceleron CFO (masshightech.com) [edit]
    Acceleron Pharma Extends Runway Through $242M Celgene Alliance (fis.dowjones.com) [edit]
    Acceleron Pharma Files for $74.75 Million IPO (biospace.com) [edit]
    Acceleron raises $93M as Celgene, investors rally around another biotech IPO (fiercebiotech.com) [edit]
Edit This Page
Last Edited 1/1/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy